ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editor Note   
  • Clin Pharmacol Biopharm 2020, Vol 9(3): 101
  • DOI: 10.4172/2167-065X.1000e101

Editor’s Note on Clinical Pharmacology and Biopharmaceutics

Francesco Marotta*
ReGenera R&D International for Aging Intervention, San Babila Clinic, Milano, Italy
*Corresponding Author: Francesco Marotta, ReGenera R&D International for Aging Intervention, San Babila Clinic, Milano, Italy, Tel: +3984143218, Email: fmarchimede@libero.it

Received: 14-Apr-2020 / Accepted Date: 22-Apr-2020 / Published Date: 28-Apr-2020 DOI: 10.4172/2167-065X.1000e101

Keywords: Pharmacology

Editorial

I am delighted to introduce journal of Clinical Pharmacology and Biopharmaceutics (CPB) of OMICS Publishing Group, one of the renowned journal in the area of pharmaceutical sciences. Clinical Pharmacology and Biopharmaceutics is an open access publication that features scientific works of all fields of pharmacy including; pharmacokinetics, pharmacodynamics, pharmacogenetics, pharmacogenomics, pharmaceutical formulation, toxicology, Applied Biopharmaceutics, Biopharmaceuticals Manufacturing and Industry, Biopharmaceuticals Process Validation, Biopharmaceutics and Drug Disposition, Clinical Drug Trials, Clinical Pharmacists, Clinical Pharmacology, etc.

The Journal is a Quarterly journal has completed 9 years started from 2011 accept original research articles, review articles, perspectives, case report, short communication, editorials etc. In the year of 2019 it has completed with 8th volume and in 2020 9th volume is going on. During 2019 total 12 number of articles has been published in 4 issues from which few are from developed countries and few from developing countries and few conference abstracts.

The objective of CPB is to publish up-to-date, high-quality and original research papers alongside relevant and insightful reviews. As such, the journal aspires to be vibrant, engaging and accessible, and at the same time integrative and challenging. Each issue of the journal will contain Research Papers, will be more traditional in form and will demonstrate a sound theoretical and methodological underpinning and a clear contribution to knowledge in the field of Pharmaceutical Sciences. All types of papers, however, will be subject to the journal’s single-blind peer review process. Needless to say, any papers that author wish to submit, either individually or collaboratively, are much appreciated and will make a substantial contribution to the early development and success of the journal.

The journal appears in many indexing sites such as; Copernicus, CAS Source Index (CASSI), Open J-Gate, Genamics JournalSeek, RefSeek, EBSCO A-Z, Publons, Sherpa Romeo, etc. It provides Membership for the journal along with reprints of the article as per authors demand. Handling social media platforms helps in journal growth. Journal uses Twitter and LinkedIn and connect with Researchers, Scientists, and Doctors worldwide to promote the published articles, new trends and news regarding pharma and biopharma along with journals to increase the page views and to get manuscripts for publication purpose.

I take this opportunity to acknowledge the contribution of Francesco Marotta during the editing of articles published and the support rendered by the Managing Editor, in bringing out issues of CPB in time.

I would also like to thank and express my gratitude to all the authors, reviewers, readers, the publisher, the advisory and the editorial board members of CPB, for their trust & endless support in bringing out another volume of “ Clinical Pharmacology and Biopharmaceutics” and looking forward for their continuous support during journal growth in upcoming days.

Copyright: © 2020 Marotta F. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Top